The association of medical providers’ attitudes about naloxone and people with opioid use disorder and their self-reported “low-barrier” treatment practices

ABSTRACT: Highlights • Low barrier buprenorphine is associated with longer treatment retention.• OUD treatment attitudes are associated with low barrier buprenorphine practices.• Naloxone attitudes were minimally related to low barrier buprenorphine practices.• Provider training should focus on the connection between attitudes and practices. Opioid-involved overdose deaths continue to climb, in part because of suboptimal access to and retention on medications for opioid use disorder (MOUD), including buprenorphine. Low barrier buprenorphine treatment aims to reduce or eliminate the threshold for getting and staying on medication by providing immediate and long-term access to buprenorphine without strict rules or requirements. This study examines associations between medical providers’ beliefs about

SUBMITTER:  

PROVIDER: S-EPMC10480593 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature